Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://repositorio.unifesp.br/handle/11600/8566 http://dx.doi.org/10.1055/s-0033-1363466 |
Resumo: | Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy. Objective Verify if the speech and language performance of children with MS whose mothers reported use of misoprostol (Cytotec, Pfizer, Connecticut, USA) are different from the performance of children of mothers who did not report use. Methods The stomatognathic system beyond receptive and expressive language and speech was evaluated in children with MS, and their mothers were questioned whether they used misoprostol during the pregnancy. Results During the interview, 61.11% of mothers reported that they took misoprostol during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech disorders (63.6%). Conclusion The number of mothers who took misoprostol without knowing the risk for MS was great. The lack of facial expressions and speech disorders were common characteristics of the individuals with MS, whether the mothers took misoprostol during the pregnancy or not. |
id |
UFSP_0b54cb9dec37ce83dd60f4d04dbfc099 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br:11600/8566 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Guedes, Zelita Caldeira FerreiraUniversidade Federal de São Paulo (UNIFESP)2015-06-14T13:47:16Z2015-06-14T13:47:16Z2014-09-01International Archives of Otorhinolaryngology. Fundação Otorrinolaringologia, v. 18, n. 3, p. 239-243, 2014.1809-4864http://repositorio.unifesp.br/handle/11600/8566http://dx.doi.org/10.1055/s-0033-1363466S1809-48642014000300239.pdfS1809-4864201400030023910.1055/s-0033-1363466Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy. Objective Verify if the speech and language performance of children with MS whose mothers reported use of misoprostol (Cytotec, Pfizer, Connecticut, USA) are different from the performance of children of mothers who did not report use. Methods The stomatognathic system beyond receptive and expressive language and speech was evaluated in children with MS, and their mothers were questioned whether they used misoprostol during the pregnancy. Results During the interview, 61.11% of mothers reported that they took misoprostol during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech disorders (63.6%). Conclusion The number of mothers who took misoprostol without knowing the risk for MS was great. The lack of facial expressions and speech disorders were common characteristics of the individuals with MS, whether the mothers took misoprostol during the pregnancy or not.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Department of Speech and LanguageUNIFESP, EPM, Department of Speech and LanguageSciELO239-243engFundação OtorrinolaringologiaInternational Archives of Otorhinolaryngologymisoprostolspeech disordersrehabilitation of speech and language disordersMöbius Syndrome: Misoprostol Use and Speech and Language Characteristicsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALS1809-48642014000300239.pdfapplication/pdf128164${dspace.ui.url}/bitstream/11600/8566/1/S1809-48642014000300239.pdfbe5c1453458c7c56b3faddd50c343af5MD51open accessTEXTS1809-48642014000300239.pdf.txtS1809-48642014000300239.pdf.txtExtracted texttext/plain22915${dspace.ui.url}/bitstream/11600/8566/2/S1809-48642014000300239.pdf.txtef2152d63dda5579fa4a5b51d8364fb9MD52open access11600/85662021-10-01 11:35:41.807open accessoai:repositorio.unifesp.br:11600/8566Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652021-10-01T14:35:41Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.en.fl_str_mv |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
spellingShingle |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics Guedes, Zelita Caldeira Ferreira misoprostol speech disorders rehabilitation of speech and language disorders |
title_short |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_full |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_fullStr |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_full_unstemmed |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
title_sort |
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics |
author |
Guedes, Zelita Caldeira Ferreira |
author_facet |
Guedes, Zelita Caldeira Ferreira |
author_role |
author |
dc.contributor.institution.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Guedes, Zelita Caldeira Ferreira |
dc.subject.eng.fl_str_mv |
misoprostol speech disorders rehabilitation of speech and language disorders |
topic |
misoprostol speech disorders rehabilitation of speech and language disorders |
description |
Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy. Objective Verify if the speech and language performance of children with MS whose mothers reported use of misoprostol (Cytotec, Pfizer, Connecticut, USA) are different from the performance of children of mothers who did not report use. Methods The stomatognathic system beyond receptive and expressive language and speech was evaluated in children with MS, and their mothers were questioned whether they used misoprostol during the pregnancy. Results During the interview, 61.11% of mothers reported that they took misoprostol during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech disorders (63.6%). Conclusion The number of mothers who took misoprostol without knowing the risk for MS was great. The lack of facial expressions and speech disorders were common characteristics of the individuals with MS, whether the mothers took misoprostol during the pregnancy or not. |
publishDate |
2014 |
dc.date.issued.fl_str_mv |
2014-09-01 |
dc.date.accessioned.fl_str_mv |
2015-06-14T13:47:16Z |
dc.date.available.fl_str_mv |
2015-06-14T13:47:16Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
International Archives of Otorhinolaryngology. Fundação Otorrinolaringologia, v. 18, n. 3, p. 239-243, 2014. |
dc.identifier.uri.fl_str_mv |
http://repositorio.unifesp.br/handle/11600/8566 http://dx.doi.org/10.1055/s-0033-1363466 |
dc.identifier.issn.none.fl_str_mv |
1809-4864 |
dc.identifier.file.none.fl_str_mv |
S1809-48642014000300239.pdf |
dc.identifier.scielo.none.fl_str_mv |
S1809-48642014000300239 |
dc.identifier.doi.none.fl_str_mv |
10.1055/s-0033-1363466 |
identifier_str_mv |
International Archives of Otorhinolaryngology. Fundação Otorrinolaringologia, v. 18, n. 3, p. 239-243, 2014. 1809-4864 S1809-48642014000300239.pdf S1809-48642014000300239 10.1055/s-0033-1363466 |
url |
http://repositorio.unifesp.br/handle/11600/8566 http://dx.doi.org/10.1055/s-0033-1363466 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
International Archives of Otorhinolaryngology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
239-243 |
dc.publisher.none.fl_str_mv |
Fundação Otorrinolaringologia |
publisher.none.fl_str_mv |
Fundação Otorrinolaringologia |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
bitstream.url.fl_str_mv |
${dspace.ui.url}/bitstream/11600/8566/1/S1809-48642014000300239.pdf ${dspace.ui.url}/bitstream/11600/8566/2/S1809-48642014000300239.pdf.txt |
bitstream.checksum.fl_str_mv |
be5c1453458c7c56b3faddd50c343af5 ef2152d63dda5579fa4a5b51d8364fb9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
|
_version_ |
1802764117242544128 |